Optimizing CAR-T Therapy for Glioblastoma

0
50
Investigators discuss current and future strategies being developed to optimize chimeric antigen receptor (CAR) T cells for efficacy in patients with glioblastoma.
[Molecular Diagnosis & Therapy]
Abstract